Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/23/2003WO2003047743A3 Method for the synthesis of uniquely d-peptides and peptide nucleic acids
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003033663A3 Rankl mimics and uses thereof
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003030825A3 CCAAT/ENHANCER BINDING PROTEIN-β (C/EBPβ IS A MOLECULAR TARGET FOR CANCER TREATMENT
10/23/2003WO2003027320A3 Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
10/23/2003WO2003025135A3 Genes associated with malignant neoplasms
10/23/2003WO2003025130A3 Receptors and membrane-associated proteins
10/23/2003WO2003020965A3 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
10/23/2003WO2003020875A3 Staphylococci surface-exposed immunogenic polypeptides
10/23/2003WO2003016465A3 Cell cycle regulator protein
10/23/2003WO2003011908A3 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
10/23/2003WO2003010293A3 Maize basal layer antimicrobial protein polynucleotides and methods of use
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003006654A3 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
10/23/2003WO2003006630A3 Nucleic acid free ghost preparations
10/23/2003WO2003006622A3 Nuclear fertility restorer genes and methods of use in plants
10/23/2003WO2003006484A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/23/2003WO2003005888A3 Lipophilin complexes for use in cancer diagnosis and therapy
10/23/2003WO2003004610A3 Hsst and angiogenesis
10/23/2003WO2003002602A3 Nogo and nogo receptor derived peptides for t-cell mediated neuroprotection
10/23/2003WO2003000906A3 Plant disease resistance genes
10/23/2003WO2002103060A3 Enterovirus nucleic acids and methods for detecting enterovirus
10/23/2003WO2002100895A3 Antimicrobially active peptide
10/23/2003WO2002099084A3 Composite binding polypeptides
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002088346A3 A system for inducible expression in eukaryotic cells
10/23/2003WO2002083723A3 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/23/2003WO2002081745A3 Genes involved in osteogenesis, and methods of use
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002081518A3 Proteins, polynucleotides encoding them and methods of using the same
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002077163A3 Drought- and salt-resistant plants by abi5 overexpression
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002062380A3 Chlamydia vaccine composition
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002055536A3 Regulation of target protein activity through modifier proteins
10/23/2003WO2002048173A3 Expression of a cadherin-like protein in benign prostatic hyperplasia
10/23/2003WO2002047720A3 Treatment and prevention of ebv infection and ebv-associated disorders
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2002036630A3 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof
10/23/2003WO2002036617A3 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003WO2001004285A8 Maize msi polynucleotides and methods of use
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003US20030200567 Isolation and identification of a gene encoding the calreticulin -interacting polypeptide (CRTintP)
10/23/2003US20030200566 Commercial production of insulin and insulin-like proteins in plants
10/23/2003US20030200564 Starch modification
10/23/2003US20030200562 Geminivirus resistant transgenic plants
10/23/2003US20030200561 Transgenic plants expressing puroindolines and methods for producing such plants
10/23/2003US20030200558 Enhanced proteins and methods for their use
10/23/2003US20030200557 Transcriptional initiation regions/gene expression cassettes isolated from plant genes for actin-2, enolase, Gos-2 genes, and L41 genes; transgenic plants
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199684 Novel gene involved in brassinosteroid responses
10/23/2003US20030199683 For diagnosing and treating related disorders
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199677 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
10/23/2003US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199672 Mixture of glucagon-like peptide-I (GLP-1) having a lipophilic substituent such as N-epsilon-tetradecanoyllysine, and a surfactant; treating obesity and non insulin-dependent diabetes mellitus (NIDDM); protracted profile of action
10/23/2003US20030199671 For protein isolation and purification
10/23/2003US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products
10/23/2003US20030199468 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences
10/23/2003US20030199465 For detection and therapy of a broad range of pathological states
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199452 Antigenic peptides reacting with anti-ovary antibodies
10/23/2003US20030199450 Regulation of cytokine synthesis and release
10/23/2003US20030199443 Novel FGF homologs
10/23/2003US20030199442 Isolated polypeptides including amino acid sequences selected from mature forms of the amino acid sequences selected from the group consisting of SEQ ID NO:2n; assay for the level of a protein effector for comparison and evaluation
10/23/2003US20030199441 Procollagen (III) Propeptides and Related Substances for Treating Fibrotic Diseases
10/23/2003US20030199438 Method for identification of proteins from intracellular bacteria
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199423 ICAM-related protein
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199093 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells
10/23/2003US20030199092 By increasing level of ribosome receptor
10/23/2003US20030199074 Cold-adapted equine influenza viruses
10/23/2003US20030199071 Mutant E. coli FimH proteins and peptides that elicit antibodies that inhibit binding of FimH to mannose than antibodies elicited by wild type FimH
10/23/2003US20030199070 Crystallization of ribosome recycling factor (RRF) and method of developing inhibitor of RRF
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences
1 ... 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 ... 2916